共 120 条
[1]
Scales CD(2012)Prevalence of kidney stones in the United States Eur Urol 62 160-165
[2]
Smith AC(2017)Burden of urolithiasis: trends in prevalence, treatments, and costs Eur Urol Focus 3 18-26
[3]
Hanley JM(2017)Kidney stones Nat Rev Dis Primers 63 871-880
[4]
Saigal CS(2014)Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review Gut 102 942-950
[5]
Raheem OA(2007)The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use Am J Gastroenterol 9 3495-3505
[6]
Khandwala YS(2012)Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium Mol Pharm 9 2282-756
[7]
Sur RL(2019)Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis Sci Rep 151 755-801
[8]
Ghani KR(2020)Use of proton pump inhibitors increases risk of incident kidney stones Clin Gastroenterol Hepatol 19 798-150
[9]
Denstedt JD(2009)Hypomagnesemia induced by several proton-pump inhibitors Ann Intern Med 3 1-2309
[10]
Khan SR(2014)Proton-pump inhibitor use is associated with lower urinary magnesium excretion Nephrology 42 2304-472